LHCSX Mutual Fund (Lord Abbett Health Care Fund Class R4) is managed by Lord Abbett Family of Funds. LHCSX expense ratio is 1.03%, holding 64 positions across sectors including Health Care, Unknown, Other. Inception date: 2019-07-31.

LHCSX performance shows a YTD return of 4.58%. The 1-year return is 27.30% and the 5-year return is 5.62%. LHCSX dividend yield stands at 0.15%, paid annually.

LHCSX top holdings include Eli Lilly & Co (8.9%), AstraZeneca PLC (4.7%), Gilead Sciences Inc (4.3%), Johnson & Johnson (3.2%), Nektar Therapeutics (3.2%). View all LHCSX holdings, sector breakdown, or dividend history.

LHCSX can be compared against other funds using the overlap calculator or side-by-side comparison tool. LHCSX alternatives are available via the screener, along with tax-loss harvesting opportunities.